HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glucosamine-6-phosphate isomerase

Also Known As:

GlcN6P deaminase; NagB protein, E coli; glucosamine-6-phosphate deaminase; glucosamine-6-phosphate deaminase, E coli; glucosaminephosphate isomerase

Networked: 9 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Isomerases: 463
    - Intramolecular Oxidoreductases
      - Aldose-Ketose Isomerases
        glucosamine-6-phosphate isomerase: 9

Experts

1.	Chen, Junhui: 1 article (01/2020)
2.	Cheng, Xianyi: 1 article (01/2020)
3.	Li, Dezhi: 1 article (01/2020)
4.	Zheng, Wei: 1 article (01/2020)
5.	Ma, Feifei: 1 article (01/2019)
6.	Mi, Jie: 1 article (01/2019)
7.	Wu, Jianxin: 1 article (01/2019)
8.	Wu, Lijun: 1 article (01/2019)
9.	Zhang, Mei-Xian: 1 article (01/2019)
10.	Zhao, Xiaoyuan: 1 article (01/2019)

Related Diseases

1.	Obesity 01/10/2018 - "Objective: To examine the association between rs10938397 polymorphism in glucosamine-6-phosphate deaminase 2 (GNPDA2) and risk of obesity in children at different stages of development and analyze the differences in the association. " 10/17/2022 - "Selected ORGs expression, namely the fat mass and obesity-associated (FTO), melanocortin-4 receptor (MC4R), glucosamine-6-phosphate deaminase 2 (GNPDA2), and transmembrane protein 18 (TMEM18) were evaluated in testes and spermatozoa by a quantitative polymerase chain reaction (qPCR). " 01/01/2019 - "Genome-wide association studies have found an obesity-related single-nucleotide polymorphism rs10938397 near the glucosamine-6-phosphate deaminase 2 gene (GNPDA2) encoding, an enzyme that catalyzes the deamination of the glucosamine-6-phosphate involved in the hexosamine signaling pathway, but the molecular mechanisms underlying the missing link between GNPDA2 and obesity remain elusive. " 12/01/2009 - "There is evidence that the obesity phenotype in the Caucasian populations is associated with variations in several genes, including neuronal growth regulator 1 (NEGR1), SEC16 homolog B (SCE16B), transmembrane protein 18 (TMEM18), ets variant 5 (ETV5), glucosamine-6-phosphate deaminase 2 (GNPDA2), prolactin (PRL), brain-derived neurotrophic factor (BDNF), mitochondrial carrier homolog 2 (MTCH2), Fas apoptotic inhibitory molecule 2 (FAIM2), SH2B adaptor protein 1 (SH2B1), v-maf musculoaponeurotic fibrosarcoma oncogene homolog (MAF), Niemann-Pick disease, type C1 (NPC1), melanocortin 4 receptor (MC4R) and potassium channel tetramerisation domain containing 15 (KCTD15). "
2.	Neoplasms (Cancer) 01/01/2020 - "Erratum: Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma [Corrigendum]." 01/01/2020 - "Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma."
3.	Hepatocellular Carcinoma (Hepatoma) 01/01/2020 - "Erratum: Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma [Corrigendum]." 01/01/2020 - "Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma."
4.	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 12/01/2009 - "There is evidence that the obesity phenotype in the Caucasian populations is associated with variations in several genes, including neuronal growth regulator 1 (NEGR1), SEC16 homolog B (SCE16B), transmembrane protein 18 (TMEM18), ets variant 5 (ETV5), glucosamine-6-phosphate deaminase 2 (GNPDA2), prolactin (PRL), brain-derived neurotrophic factor (BDNF), mitochondrial carrier homolog 2 (MTCH2), Fas apoptotic inhibitory molecule 2 (FAIM2), SH2B adaptor protein 1 (SH2B1), v-maf musculoaponeurotic fibrosarcoma oncogene homolog (MAF), Niemann-Pick disease, type C1 (NPC1), melanocortin 4 receptor (MC4R) and potassium channel tetramerisation domain containing 15 (KCTD15). "
5.	Fibrosarcoma 12/01/2009 - "There is evidence that the obesity phenotype in the Caucasian populations is associated with variations in several genes, including neuronal growth regulator 1 (NEGR1), SEC16 homolog B (SCE16B), transmembrane protein 18 (TMEM18), ets variant 5 (ETV5), glucosamine-6-phosphate deaminase 2 (GNPDA2), prolactin (PRL), brain-derived neurotrophic factor (BDNF), mitochondrial carrier homolog 2 (MTCH2), Fas apoptotic inhibitory molecule 2 (FAIM2), SH2B adaptor protein 1 (SH2B1), v-maf musculoaponeurotic fibrosarcoma oncogene homolog (MAF), Niemann-Pick disease, type C1 (NPC1), melanocortin 4 receptor (MC4R) and potassium channel tetramerisation domain containing 15 (KCTD15). "

Related Drugs and Biologics

1.	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)
2.	Proteins (Proteins, Gene)
3.	Enzymes
4.	Brain-Derived Neurotrophic Factor (BDNF)
5.	Potassium Channels (Potassium Channel)
6.	Prolactin
7.	Polysaccharides (Glycans)
8.	Hexosamines
9.	Amino Sugars
10.	Acetylglucosamine